Current treatments and emerging therapeutic approaches in male erectile dysfunction.
Hatzichristou
D G
DG
Department of Urology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. hatzichr@med.auth.gr
Pescatori
E S
ES
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000527:Alprostadil / Q000627:therapeutic use; D001058:Apomorphine / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000628:therapy*; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy; D007093:Imidazoles / Q000627:therapeutic use; D008297:Male; D019935:Penile Implantation / Q000379:methods; D026741:Physical Therapy Modalities; D010879:Piperazines / Q000627:therapeutic use; D011613:Psychotherapy / Q000379:methods; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D013739:Testosterone / Q000627:therapeutic use; D014227:Triazines; D014618:Vacuum; D000069058:Vardenafil Dihydrochloride; D014656:Vascular Surgical Procedures / Q000379:methods; D014665:Vasodilator Agents / Q000627:therapeutic use; D015016:Yohimbine / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D007093:Imidazoles; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014227:Triazines; D014665:Vasodilator Agents; D015016:Yohimbine; D013739:Testosterone; D000069058:Vardenafil Dihydrochloride; D000068677:Sildenafil Citrate; D000527:Alprostadil; D001058:Apomorphine